FFCP PHASE2:Hg19::chr15:40987401..40987416,+
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p2@RAD51 |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_2_at_RAD51_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 16bp_to_ENST00000525066_5end |
EntrezGene: | RAD51 |
HGNC: | 9817 |
UniProt: | E9PJ30 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p2@RAD51 |
---|
0
2
4
6
8
10
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
larynx | 2.41e-09 | 9 |
upper respiratory tract | 3.72e-08 | 19 |
Showing 1 to 2 of 2 entries
Ontology term | p-value | n |
---|---|---|
cancer | 1.48e-20 | 235 |
disease of cellular proliferation | 1.84e-19 | 239 |
cell type cancer | 8.66e-13 | 143 |
carcinoma | 4.99e-11 | 106 |
hematologic cancer | 5.26e-08 | 51 |
immune system cancer | 5.26e-08 | 51 |
leukemia | 6.34e-08 | 39 |
Showing 1 to 7 of 7 entries